PEN:NYSE
Penumbra Inc
$317.55
arrow_downward
-0.14%(-0.45) 1D
$317.54
arrow_downward
-0.00% (-0.0079)bedtimeAfter hours
Closed: Oct 2, 4:00:04 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PEN...
Open
$318.37
High
$318.37
Low
$316.78
Mkt. cap
12.51B
Avg. vol.
352.00K
Volume
239.68K
P/E ratio
77.99
52-wk high
$362.41
52-wk low
$221.26
EPS
$4.07
Beta
0.70
Shares outstanding
39.39M
No. of employees
5K
Open
$318.37
High
$318.37
Low
$316.78
Mkt. cap
12.51B
Avg. vol.
352.00K
Volume
239.68K
P/E ratio
77.99
52-wk high
$362.41
52-wk low
$221.26
EPS
$4.07
Beta
0.70
Shares outstanding
39.39M
No. of employees
5K
News stories
From web sources and news partners
Zacks
·
2 days ago
IART vs. PEN: Which Stock Is the Better Value Option?
Profile
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.
In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by year-end. Wikipedia
About Penumbra Inc